The infection surveillance solutions market is estimated to be valued at US$ 683.8 Mn in 2023 and is expected to exhibit a CAGR of 14.% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:
Infection surveillance solutions are used by hospitals and healthcare facilities to track and monitor hospital acquired infections (HAIs). These solutions help analyze clinical and microbiological data to identify the source and spread of infections. They offer early detection of infections which helps clinicians and healthcare workers take prompt actions to control the spread. Common products offered are software, services and medical devices.

Market Dynamics:
The infection surveillance solutions market is primarily driven by the rising prevalence of HAIs globally. As per the Centers for Disease Control and Prevention, over 722,000 HAIs occurred in acute care hospitals in the United States in 2019. This has increased the adoption of infection surveillance and monitoring solutions by healthcare facilities to detect and control the spread of HAIs. Additionally, growing geriatric population who are more susceptible to contract infections while undergoing treatment is also fueling market growth. Furthermore, increasing government initiatives and regulatory guidelines to curb HAIs will continue boosting the demand for advanced infection surveillance solutions over the forecast period.

SWOT Analysis

Strength: Infection Surveillance Solutions help healthcare facilities reduce healthcare associated infections, improve patient safety and outcomes. The data-driven insights help optimize infection control programs. The cloud-based platforms offer 24/7 access from any device.

Weakness: High upfront costs and maintenance expenses of these solutions pose significant financial burden on healthcare facilities. Lack of skilled professionals hinders effective use of advanced analytical features.

Opportunity: Increasing government funding and initiatives to curb infections presents large market opportunity. Growing geriatric population susceptible to infections also offers scope. Integrating with other clinical systems can augment solution capabilities.

Threats: Stringent regulations around data privacy and security threaten market growth. Interoperability issues with legacy systems remain a challenge. Supplier consolidation could impact pricing and diversity.

Key Takeaways

The global Infection Surveillance Solutions market is expected to witness high growth, exhibiting a CAGR of 14% over the forecast period, due to increasing healthcare costs associated with HAI treatment and stringent regulations regarding reducing infections. North America accounted for the largest regional market share in 2022 and is expected to maintain its dominance over the forecast period, propelled by growing healthcare expenditure, technologically advanced healthcare infrastructure, and conducive regulatory environment.

Key players operating in the infection surveillance solutions market include Baxter, BD, STERIS, Getinge AB, Medtronic, Koninklijke Philips N.V., Abbott, Medexter Healthcare, Asolva, GOJO Industries, Inc., Wolters Kluwer N.V., VigiLanz Corporation, RLDatix, Roper Technologies Inc., Health Outcomes Worldwide, OpGen, Inc., Urovant Sciences and Premier. These players are focusing on new product launches, partnerships, and mergers & acquisitions to strengthen their market position. For instance, in August 2022, Medexter Healthcare partnered with Infosys to deliver AI-powered clinical surveillance for healthcare-associated infections.